About FBS: Access PDF booklet
Organization Mission: Frontiers in Bioscience (FBS) is an organization dedicated to teaching, education and research.
Organization type: Frontiers in Bioscience is a Nonprofit organization: Frontiers in Bioscience (FBS) is dedicated to fostering science, education and research. FBS was launched in 1996 as the first electronic medical journal and because of this it was indexed from the outset by the National Library of Medicine and received the 501 (c)(3) status from Internal Revenue Service in 1998. FBS is now recognized as a platinum organization as one of the top 0.5% of Non-profit organizations among 1.5 million Non-profit corporations that are assessed and indexed by GuideStar. GuideStar is one of the first central sources of information on U.S. Non-profits and is the world's largest source of information about Non-profit organizations.
Aims and Scope: Frontiers in Bioscience provides a platform where exchange of scientific information can take place freely among investigators, scientists, physicians and patients. Frontiers in Bioscience journal publishes manuscripts, books, lectures, databases and other useful information. Publishing data in scientific journals is the accepted means for dissemination of information in science. Publications are important to investigators since they reflect the extent of their scholarly activities and are needed for their promotion and are required for obtaining grants. They are also the sole accepted method for dissemination of information important to other investigators and the public. Therefore, "Frontiers in Bioscience" considers all publications as important communications. Attempts will be made to post the manuscript online in a minimum time possible after it has been accepted for publication. Frontiers in Bioscience has been constructing the largest peer reviewed "Encyclopedia of Bioscience" since 1996, with the help of over 1000 managing editors who are supporting the creation of this scientific treasure for all scientists across the globe. FBS strives to assist science industries deliver the mission of their business to thousands of scientists and decision-makers around the globe. FBS journal integrates the art of science publication with a diverse array of information, tools and techniques. The journal "Frontiers in Bioscience" is a modern forum for scientific communication. Data and information that are useful to investigators in any discipline in biology and medicine including biochemistry, microbiology, parasitology, virology, immunology, biotechnology, and bioinformatics will be published after they have been peer reviewed. This will include reviews and research articles in basic science and clinical science, as well as technical notes and protocols. Other materials that have not been traditionally published as peer reviewed articles will also be considered for publication. This will include, rare images, videos and sounds, and assimilated data in the form of a database on any subject in medicine and biology.
Revenue sources: For its operation, the Frontiers in Bioscience obtains funds from publication, subscription, reprint orders, charitable donations, fund raising and investment.
Journal title: Frontiers in Bioscience (FBS)
Publisher: Frontiers in Bioscience
Journals: Frontiers in Bioscience offers three distinct journals: Landmark, Scholar and Elite. The Landmark edition is dedicated to the publication of comprehensive reviews in molecular medicine. The Scholar edition is comprised of reviews in basic and clinical science. The Elite edition focuses on primary research articles in all fields of biology and medicine, technical notes and protocols, and multimedia medicine online (videos, sounds, images, VRML).
Journal Profile: Frontiers in Bioscience is a virtual library and a gateway to a world of science. FBS journal offers a unique blend of articles, enhanced reports on latest scientific findings, events and other cutting-edge topics affecting the success of today’s science professionals. FBS provides novel ideas, science trends, medical uses and emerging technologies.
Registration: Copyright and Trademark
Subject Terms: Science, Medicine Biology, Disease, Patient, Doctor, Physician, Database, Gene, Gene Knockout, Atlas, Embryo, Human, Mouse, Xenopus, Embryology, Pathology, Tumor, Cancer, Diagnosis, Treatment, Restriction Enzyme, Amino Acid, Elements, Heart, Anatomy, Apoptosis, Behavioral Science, Biochemistry, Bioinformatics, Biology, Biophysics, Bioremediation, Biotechnology, Cancer, Cardiology, Cell , Cell Biology, Cell Membrane, Chemistry, Cognition, Cognitive Science, Computer Science, Computing, Cytokine, Development, Developmental Biology, Earth Science, Electrophysiology, Endocrinology, Bioengineering, Environmental Science, Epidemiology, Evolution, Gene Regulation, Gene Therapy, Genetic Engineering, Genetics, Genomics, Genome, Growth Factor, HIV, Hormone, Immunology, Informatics, Kinase, Life Science, Marine Science, Materials Science, Mathematics, Medicine, Mercury, Microbiology, Molecular Biology, Morphology, Neurobiology, Neuroscience, Neurotransmitter, Nucleus, Numerical Methods, Numerical Simulations, Oncology, Optics, Pathology, Peptide, Pharmaceuticals, Pharmacology, Physical Sciences, Physics, Physiology, Protein, Psychology, Receptor, Science Careers, Science Education, Science Employment, Science Jobs, Science Journal, Science News, Science Online, Science Policy, Science Signal Transduction, Science Stories, Science Techniques, Scientific Careers, Scientific Information, Scientific Jobs, Signal Transduction, Spectroscopy, Steroid, Structural Biology, Toxicology, Universe, Veterinary Science, Virology, Sound, Encyclopedia, Bioscience, DNA, RNA, Protein, Genetic Code, Clinical data.
D-U-N-S Number: 084818389
North American Industry Classification System Number (NAICS): 611710
Standard Industrial Classification Number (SIC) : 8732
ISSN Numbers: Online: Landmark Edition: 1093-4715, Scholar Edition: 1945-0524, Elite Edition: 1945-0508, Print: Landmark Edition: 1093-9946, Scholar Edition: 1945-0516, Elite Edition: 1945-0494, CD-ROM Landmark Edition: 1094-3935, Scholar Edition: 1944-7906, Elite Edition: 1944-7892
Impact Factor: Landmark Edition: 2000-2017: 2.497- 3.95
Ranking: FBS ranks #69 of 261 journals in Biochemistry & Molecular Biology, #47 of 156 journals in Cell Biology, and #482 of 5907 journals in the Science Edition of the 2003 Journal Citation Reports.
Types of Communications: Manuscripts describing recent and important advances in the fields of biology or medicine will be considered for publication in the Frontiers in Bioscience. Publications include, Comprehensive reviews in molecular medicine, Reviews in basic and clinical sciences, Research articles in basic and clinical science, Technical notes and protocols, Multimedia medicine on line (videos, sounds and images, VRML), Databases, Proceedings of National and International Conferences, Lectures.
Journals: Landmark (1996-present), Scholar (2009-present), Elite (2009-present)
Web search for the journal: Search Google for “Frontiers in Bioscience”. Result should show up in the first top
Journal archive: Archives
Description: A journal and virtual library and a gateway to a world of science
Address: 16471 Scientific Way, Irvine, CA 92657
Editor-in-Chief: Siamak Tabibzadeh
General contact: Siamak Tabibzadeh, MD
Associate Editor: Xueji Zhang
Editors: Access Listing
Managing Editors: Access Listing
Review process: All manuscripts are peer reviewed by 2-5 reviewers. Peer review is arranged by managing editors when the document is for their special issue. Peer review is arranged by the Frontiers in Bioscience by five reviewers, if the manuscript is sent directly to the Frontiers in Bioscience. We attempt to make the peer review completed within 30 days
Conflicts of interest, Publication Ethics and Malpractice Statement FBS complies with guideline provided by Committee on Publication Ethics (COPE)(2011, March 7), Code of Conduct and Best-Practice, and Guidelines for Journal Editors. Access FBS policiesConflicts of interest can be addressed to email@example.com. The journal handles potential conflicts of interest of editors, authors, and reviewers as follows. If an editor is also an author of the manuscript, the FBS will arrange the peer review. Conflict of interest of authors should be stated clearly in the manuscript acknowledgement section. For example, the authors should state whether they have any conflict of interest particularly whether they are the founding member of a commercial company that directly benefits from publication. If the conflicts exist regarding a review, for example, one reviewer accepted the manuscript while another one requested corrections to be made, the author is informed that such changes are required to be made to the manuscript before the manuscript can be considered suitable for publication. When the two reviewers have opposing views, additional reviewers will be chosen until the majority of reviewers accept a paper with or without changes. All changes requested by the reviewers must be implemented and the authors should provide written statement of changes that they made in response to the reviewer’s queries. Finally, all other conflicts are solved by the Editor-in-Chief with authors, editors and reviewers until a final remedy is found and accepted by the involved parties.
Coverage: All fields of biology and medicine
Target audience: Scientists, Physicians, Patients, Medical Students, Residents, Fellows, Pharmacists, Biologists, Nurses
Abbrev. title: Front Biosci
Former titles: None
Month/Year: All (>1996)
Frequency: 2-4 times a year
Publishing schedule: Frontiers in Bioscience publishes articles in issues which appear during a course of three months (Jan-March, April-June, September-December) and are indexed on Jan 1, March 1 and June 1 of each year in indexing services
Lead times: 1-3 months
Publication Dates: September, March and June
Circulation Range: >400,000/year
Circulation in UK/Europe: 25%
Circulation in North America: 60%
Circulation in Japan: 1%
Acceptance criteria (regular issues): Score>75
Acceptance rate (regular issues): 30%
Acceptance rate (supplements): 30%
Author fees: The basic publication fees for articles published in the Frontiers in Bioscience which are invited by managing editors are waived. Also, basic publication fees for articles that are submitted by authors or the managing editors for a one day evaluation of their impact will be waived as well if the editorial office finds the article to be of high impact. The review process takes only one day. Also, the publication fee is waived for scientists who do not have an active grant. The publication fee will be applied only to those articles that are submitted to the editorial office without prior impact determination, or if the authors request special publication features such as express open access, fasttrack publication, open access, reprints, or subscription. Access the publication forms before submission.
Reprint delivery: Yes. Choose article and order reprints
Rights and permissions: Required; Access the Rights and Permissions form
Online facilities: Full Text HTML with links, PDF
Indexing/Abstracting: Landmark: Science Citation Index Expanded, Current Contents - Life Sciences, Zoological Record, BIOSIS Previews, Web of Science, PubMed, Index Medicus, MEDLINE, Research Alert, Current Web Content, Chemical Abstracts, CrossRef. For complete listing of impact, access Impact For finding articles resolved by DOI in CrossRef use the DOI prefix followed by the publication number such as http://dx.doi.org/10.2741/article number. Scholar and Elite Editions: PubMed, Index Medicus, MEDLINE, Chemical Abstracts, CrossRef
Number of articles published: Access Archives
Jobs: Access Listing